NY-SECURITYSCORECARD
12.9.2022 10:02:00 CEST | Business Wire | Press release
Leading IT services provider NTT DATA UK&I and SecurityScorecard, the global leader in cyber security ratings, today announced a new partnership to accelerate the transformation of continuous cyber risk monitoring across industries across the UK and Ireland (UK&I). As part of the partnership, NTT DATA will deliver an innovative posture evaluation report offering for clients, based on the SecurityScorecard platform. The report will combine NTT DATA’s consulting expertise with SecurityScorecard’s ratings and assessment capabilities to instantly rate, analyse and continuously monitor security risk for clients, as well as harden their security postures.
In today’s ever-evolving cyber security landscape, organisations must be proactive in addressing cyber breaches, and security ratings are integral to measuring and understanding resilience in real time. NTT DATA understands the importance of this and is doubling its efforts in the cyber security space as a result, ensuring its clients are best equipped to handle new threats on a regular basis. It is for this reason that SecurityScorecard has joined the likes of Adobe and Microsoft in becoming a Tier 1 strategic partner for NTT DATA UK&I.
From non-executive directors through to IT operations teams, businesses’ stakeholders call out three critical board-level risks – data loss, cyber breach, and third-party exposure. These risks are typically grounded in common challenges, such as enterprise visibility, poor information clarity or translation, and confused response prioritisation, but are stressed further by an industry-wide shortage of competent security knowledge and skills. The partnership between NTT DATA and SecurityScorecard will address these client challenges head-on, bringing together industry-leading core competencies, industry sector insights, deep client knowledge, and strategic client relationships.
Mike Jones, VP of Partners & Alliances at NTT DATA (UK&I), commented: “NTT DATA is proud of its global ecosystem of Partners & Alliances, which helps bring value to our clients through transformational change. We’re delighted to announce our latest partnership with SecurityScorecard, the global leader in cybersecurity ratings, to help NTT DATA identify security threats as well as keep clients safe and secure.”
SecurityScorecard provides comprehensive security ratings, automated assessments, and guidance from industry experts, providing easy-to-understand A-F graded scorecards for improved communication, effective compliance reporting and more informed decision making. The solution allows organisations to automate and accelerate questionnaire exchange with over 20 compliance survey templates and questionnaires at scale.
“Our partnership with NTT DATA immediately gives customers in EMEA more complete visibility into the risks that exist in their environment, and guidance in reducing that risk most effectively, all in a single platform,” said Jan Bau, VP EMEA and LATAM at SecurityScorecard. “This will enable organisations across NTT DATA’s portfolio to proactively ensure they have continuous and immediate insights on their security posture.”
Through the partnership, SecurityScorecard will embed a suite of cyber security monitoring solutions into NTT DATA’s managed service offering to create a monthly posture evaluation report. The report will allow businesses to understand their true cyber risk and will enable them to instantly improve their security postures through much-needed data, visibility, and insights. As well as insights from the platform, the monthly service will benefit from NTT DATA’s advisory and threat intelligence capabilities, providing not just an overview of a client’s industry sector, but an overview of their vendors and business partners as well, delivering additional value to clients in the areas they want to target the most.
Jones added, “NTT DATA places huge importance on cyber resilience and our new posture evaluation solution has been built to provide our clients with peace of mind when it comes to their cyber security. Not only will our reporting tool share a holistic overview of their security measures, but clients will be able to rest easy knowing they have identified all potential areas of vulnerability and implemented the right solutions to protect their critical infrastructure.”
For more information about SecurityScorecard and NTT DATA UK&I, visit the SecurityScorecard booth at the Gartner UK Security & Risk Summit, Stand 105 from September 12 through the 14.
About NTT DATA
NTT DATA is the world’s second largest managed security services provider, with over 5,500 information and cyber security professionals globally. Headquartered in Tokyo, and with business operations in over 50 countries, NTT DATA’s security practice provides Security Consulting, Engineering, Managed Services and accelerated partnered product solutions that align with its clients’ business goals, as well as meet speed, cost, quality, and regulatory needs. NTT DATA’s emphasis is on long-term commitment, combining Security Operations Centres (SOCs) and local delivery capabilities to provide premier professional services on a global scale. For more information, visit: uk.nttdata.com
About SecurityScorecard
Funded by world-class investors including Evolution Equity Partners, Silver Lake Waterman, Sequoia Capital, GV, Riverwood Capital, and others, SecurityScorecard is the global leader in cybersecurity ratings with more than 12 million companies continuously rated. Founded in 2013 by security and risk experts Dr. Aleksandr Yampolskiy and Sam Kassoumeh, SecurityScorecard's patented rating technology is used by over 30,000 organisations for enterprise risk management, third-party risk management, board reporting, due diligence, cyber insurance underwriting, and regulatory oversight. SecurityScorecard is the first cybersecurity ratings company to offer digital forensics and incident response services, providing a 360-degree approach to security prevention and response for its worldwide customer and partner base. SecurityScorecard continues to make the world a safer place by transforming the way companies understand, improve and communicate cybersecurity risk to their boards, employees and vendors. Every organisation has the universal right to their trusted and transparent Instant SecurityScorecard rating. For more information, visit securityscorecard.com or connect with us on LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220912005192/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
